Iron deficiency in the elderly population, revisited in the hepcidin era.

PubWeight™: 0.89‹?›

🔗 View Article (PMC 4006029)

Published in Front Pharmacol on April 23, 2014

Authors

Fabiana Busti1, Natascia Campostrini1, Nicola Martinelli1, Domenico Girelli1

Author Affiliations

1: Department of Medicine, University of Verona Verona, Italy.

Articles cited by this

IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest (2004) 11.05

Anemia of chronic disease. N Engl J Med (2005) 10.88

Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood (2002) 7.58

Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. Blood (2004) 5.86

The definition of anemia: what is the lower limit of normal of the blood hemoglobin concentration? Blood (2005) 5.58

Acquired von Willebrand syndrome in aortic stenosis. N Engl J Med (2003) 5.33

Immunoassay for human serum hepcidin. Blood (2008) 5.32

Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood (2003) 5.11

The origins of age-related proinflammatory state. Blood (2004) 4.15

A clinical evaluation of serum ferritin as an index of iron stores. N Engl J Med (1974) 3.92

Screening for colorectal cancer. Ann Intern Med (1990) 3.81

Diagnosis of iron-deficiency anemia in the elderly. Am J Med (1990) 3.77

A prospective study of anemia status, hemoglobin concentration, and mortality in an elderly cohort: the Cardiovascular Health Study. Arch Intern Med (2005) 3.14

Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency. Blood (1997) 3.14

The definition of anemia in older persons. JAMA (1999) 3.09

Interleukin-6 in aging and chronic disease: a magnificent pathway. J Gerontol A Biol Sci Med Sci (2006) 2.85

The prevalence of Helicobacter pylori infection in different countries. Aliment Pharmacol Ther (1995) 2.84

Systemic iron homeostasis. Physiol Rev (2013) 2.69

Hepcidin and disorders of iron metabolism. Annu Rev Med (2011) 2.67

FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease. Gastroenterology (2011) 2.64

Impact of anemia on mortality, cognition, and function in community-dwelling elderly. Am J Med (2006) 2.58

Safety in iron management. Am J Kidney Dis (2003) 2.56

From clinical observation to mechanism--Heyde's syndrome. N Engl J Med (2012) 2.44

Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications. Blood (2009) 2.41

Hepcidin and hemoglobin content parameters in the diagnosis of iron deficiency in rheumatoid arthritis patients with anemia. Arthritis Rheum (2011) 2.38

Guidelines for the management of iron deficiency anaemia. Gut (2011) 2.28

Anemia of inflammation: the cytokine-hepcidin link. J Clin Invest (2004) 2.25

Diagnosis of iron deficiency anemia in the elderly by transferrin receptor-ferritin index. Arch Intern Med (2002) 2.23

Proinflammatory state, hepcidin, and anemia in older persons. Blood (2010) 2.19

What constitutes normal hemoglobin concentration in community-dwelling disabled older women? J Am Geriatr Soc (2004) 2.18

Serum ferritin concentration and bone marrow iron stores: a prospective study. Can Med Assoc J (1978) 2.14

Effect of anemia and comorbidity on functional status and mortality in old age: results from the Leiden 85-plus Study. CMAJ (2009) 2.11

Increased prevalence of aortic stenosis in patients with arteriovenous malformations of the gastrointestinal tract in Heyde syndrome. Arch Intern Med (2003) 2.09

Impact of anemia on hospitalization and mortality in older adults. Blood (2006) 2.07

Anaemia in the elderly: an aetiologic profile of a prospective cohort of 95 hospitalised patients. Eur J Intern Med (2012) 2.05

Detection, evaluation, and management of iron-restricted erythropoiesis. Blood (2010) 1.93

Anemia in older adults. Curr Opin Hematol (2005) 1.86

Anemia in old age is associated with increased mortality and hospitalization. J Gerontol A Biol Sci Med Sci (2006) 1.83

Serum hepcidin: reference ranges and biochemical correlates in the general population. Blood (2011) 1.79

Diagnosis and management of iron-deficiency anaemia. Best Pract Res Clin Haematol (2005) 1.79

Diagnosis and management of iron deficiency anaemia: a clinical update. Med J Aust (2010) 1.78

Iron deficiency anemia. Nutr Clin Pract (2008) 1.68

Safety and efficacy of rapidly administered (one hour) one gram of low molecular weight iron dextran (INFeD) for the treatment of iron deficient anemia. Am J Hematol (2011) 1.65

Increasing prevalence and high incidence of celiac disease in elderly people: a population-based study. BMC Gastroenterol (2009) 1.65

Parenteral iron therapy options. Am J Hematol (2004) 1.63

Anemia in the elderly: current understanding and emerging concepts. Blood Rev (2006) 1.55

Clinical use of intravenous iron: administration, efficacy, and safety. Hematology Am Soc Hematol Educ Program (2010) 1.52

Hepcidin in human iron disorders: diagnostic implications. Clin Chem (2011) 1.50

Epidemiology of anemia in older adults. Semin Hematol (2008) 1.45

Clinical utility of the soluble transferrin receptor and comparison with serum ferritin in several populations. Clin Chem (1998) 1.37

A mouse model of anemia of inflammation: complex pathogenesis with partial dependence on hepcidin. Blood (2013) 1.34

The liver: conductor of systemic iron balance. Blood (2013) 1.30

Association of HFE and TMPRSS6 genetic variants with iron and erythrocyte parameters is only in part dependent on serum hepcidin concentrations. J Med Genet (2011) 1.28

Iron deficiency anemia: diagnosis and management. Curr Opin Gastroenterol (2009) 1.24

Serum hepcidin as a diagnostic test of iron deficiency in premenopausal female blood donors. Haematologica (2011) 1.21

Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis. Blood Cells Mol Dis (2007) 1.20

Hepcidin levels predict nonresponsiveness to oral iron therapy in patients with iron deficiency anemia. Am J Hematol (2013) 1.19

Unexplained anemia in the elderly. Semin Hematol (2008) 1.18

Evaluation of an automated soluble transferrin receptor (sTfR) assay on the Roche Hitachi analyzer and its comparison to two ELISA assays. Clin Chim Acta (2007) 1.17

A multicenter, randomized, active-controlled study to investigate the efficacy and safety of intravenous ferric carboxymaltose in patients with iron deficiency anemia. Transfusion (2013) 1.16

Distinct roles for hepcidin and interleukin-6 in the recovery from anemia in mice injected with heat-killed Brucella abortus. Blood (2013) 1.15

Safety of long-term PPI therapy. Best Pract Res Clin Gastroenterol (2013) 1.15

Review article: gastrointestinal angiodysplasia - pathogenesis, diagnosis and management. Aliment Pharmacol Ther (2013) 1.14

Anemia in elderly patients: an emerging problem for the 21st century. Hematology Am Soc Hematol Educ Program (2010) 1.14

Iron isomaltoside 1000: a new intravenous iron for treating iron deficiency in chronic kidney disease. J Nephrol (2011) 1.12

Anemia in older persons: etiology and evaluation. Blood Cells Mol Dis (2011) 1.07

Nutritional anemias and the elderly. Semin Hematol (2008) 1.06

Angiodysplasia. Clinical presentation and colonoscopic diagnosis. Dig Dis Sci (1984) 1.06

Anemia in celiac disease is multifactorial in etiology. Am J Hematol (2007) 1.04

Adult celiac disease in the elderly. World J Gastroenterol (2008) 1.03

Severe iron deficiency blunts the response of the iron regulatory gene Hamp and pro-inflammatory cytokines to lipopolysaccharide. Haematologica (2010) 1.01

Hepcidin assay in serum by SELDI-TOF-MS and other approaches. J Proteomics (2009) 0.99

Iron deficiency syndromes and iron-restricted erythropoiesis (CME). Transfusion (2011) 0.99

Serum ferritin and ageing. Age Ageing (1981) 0.95

Celiac disease in the elderly. Gastroenterol Clin North Am (2009) 0.95

Erythropoietin, GDF15, IL6, hepcidin and testosterone levels in a large cohort of elderly individuals with anaemia of known and unknown cause. Eur J Haematol (2011) 0.95

How I treat unexplained refractory iron deficiency anemia. Blood (2013) 0.92

Serum hepcidin in inflammatory bowel diseases: biological and clinical significance. Inflamm Bowel Dis (2013) 0.91

Safety and efficacy of total dose infusion of 1,020 mg of ferumoxytol administered over 15 min. Am J Hematol (2013) 0.89

Iron: the new advances in therapy. Best Pract Res Clin Anaesthesiol (2013) 0.89

Hepcidin and ferroportin: the new players in iron metabolism. Semin Liver Dis (2011) 0.88

Diagnosis of iron-deficiency anemia in a hospitalized geriatric population. Am J Med (1991) 0.87

Evaluation and management of anemia in the elderly. Am J Hematol (2014) 0.85

Investigation of the role of interleukin-6 and hepcidin antimicrobial peptide in the development of anemia with age. Haematologica (2013) 0.85

Plasma hepcidin levels and anemia in old age. The Leiden 85-Plus Study. Haematologica (2012) 0.83

Celiac disease in the elderly. Gerontology (2005) 0.83

Anemia in elderly patients: new insight into an old disorder. Geriatr Gerontol Int (2012) 0.83

Serum levels of the hepcidin-20 isoform in a large general population: the Val Borbera study. J Proteomics (2012) 0.83

Iron status in the elderly. Mech Ageing Dev (2013) 0.82

Using longitudinal data from the Health Survey for England to resolve discrepancies in thresholds for haemoglobin in older adults. Br J Haematol (2012) 0.81